ABILITY NeuroTech announces first in-human testing for novel brain-computer interface technology

ABILITY Neurotech has commenced its first in-human clinical trial for its brain-computer interface (BCI) technology in Germany. The study, conducted at the Technical University of Munich, aims to validate the system's ability to capture high-quality neural data during surgery, a key step towards developing long-term implants for patients with severe neurological impairment.

This Wire brief sits within Fusion42's coverage of Medtech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.